Main > HEPATOLOGY > USA. I. PBC>Treat.>FXR Agonist Tab.

---

USA. I. PBC>Treat.>FXR Agonist Tab.'s subsections
(*) CA Approval Date: 2017. 05.25
(*) EU CE Mark Date: 2016. 12.14
(*) USA Approval Date: 2016. 05.27
Company
Company Marketing Ex USA
FXR: Farnesoid X Receptor
Generic Name: ObetiCholic Acid
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 11
Patent>UpDate: 2022. 07.19
PBC: Primary Biliary Cholangitis/Ci
RTM
RTM Web-Site

USA. I. PBC>Treat.>FXR Agonist Tab.'s products
This section has no products